Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Metzler VM, de Brot S, Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, et al. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Front Cell Dev Biol. 2023;11:1116424.

Santo EE, Ribel-Madsen R, Stroeken PJ, de Boer VC, Hansen NS, Commandeur M, et al. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity. Aging Cell. 2023;22(3):e13763.

Schreidah CM, Fahmy LM, Lapolla BA, Kwinta BD, Magro CM, Geskin LJ. Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. Am J Dermatopathol. 2023;45(8):572-576.

Geyer JT, Kluk MJ. Current Landscape of Ancillary Diagnostic Testing in Chronic Lymphocytic Leukemia. Surg Pathol Clin. 2023;16(2):411-421.

Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, et al. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023;141(18):2194-2205.

Greenblatt M, Debnath S, Yallowitz A, McCormick J, Lalani S, Zhang T, et al. Identification of a stem cell mediating osteoblast versus adipocyte lineage selection. Res Sq. 2023.

Ahmad M, Warren L, Ingyin H, Naumaan A, Da Silva AF. Primary Vaginal Epithelioid Angiosarcoma: A Case Report and Literature Review of a Rare Neoplasm. Cureus. 2023;15(5):e39258.

Li J, Chin CR, Ying H-, Meydan C, Teater MR, Xia M, et al. Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas. bioRxiv. 2023.

Yeshoua B, Bowman C, Dullea J, Ditkowsky J, Shyu M, Lam H, et al. Interventions to reduce repetitive ordering of low-value inpatient laboratory tests: a systematic review. BMJ Open Qual. 2023;12(1).

Zuckerman AL, Pourvaziri A, Ebb DH, Boyraz B. Case 26-2023: A 15-Year-Old Girl with Abdominal Pain and an Ovarian Mass. N Engl J Med. 2023;389(8):750-758.